Sujay Srinivas

5PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial.

Vikas Ostwal, Manali Parulekar, Deepali Naughane

|Aug 05, 2024
Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma (BEER BTC): A Multicenter, Open-Label, Randomized, Phase II Trial.

Anant Ramaswamy, Prabhat Bhargava, Sujay Srinivas

|May 09, 2024
Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India.

Jyoti Bajpai, Pritesh Munot, Kishore Kota

|Nov 30, 2023
Survival of Trial-Like and Non-Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP).

Anant Ramaswamy, Anand Kulkarni, George John

|Nov 09, 2023
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB).

Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava

Pageof 1

Frequent Collaborators

5 joint publications

Vikas Ostwal

5 joint publications

Prabhat Bhargava

4 joint publications

Anant Ramaswamy

3 joint publications

Akhil Kapoor